Select language:  
1800 620 420
Close menu

Expert Series: Associate Professor Nada Hamad on the importance of clinical trials

When talking to her patients, clinical haematologist and researcher Associate Professor Nada Hamad always considers their eligibility for a clinical trial. 

  • Chronic lymphocytic leukaemia
  • Interviews with experts
  • Research
  • Treatments and side-effects
Read more
Associate Professor Nada Hamad - clinical haematologist and researcher

Increased melanoma risk in CLL patients means regular skin checks critical

People with chronic lymphocytic leukaemia (CLL) have a sizeable 600% higher risk of the most dangerous form of skin cancer, melanoma, researchers have found.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Skin check

In My Own Words: Patrick Griffin was told he had months to live after a third cancer diagnosis

Patrick Griffin's overcame prostate cancer, then lymphoma, before being diagnosed with CLL.

  • Chronic lymphocytic leukaemia
Read more
Patrick Griffin and his CLL medication

Being immunocompromised makes CLL patients one of the most vulnerable patient groups

Clinical haematologist and researcher, Associate Professor Nada Hamad discusses the latest on CLL.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Diana Brown

Women in haematology: spotlight on Associate Professor Nada Hamad

Getting to know the clinical haematologist and researcher,

  • Chronic lymphocytic leukaemia
Read more
Associate Professor Nada Hamad - clinical haematologist and researcher

Phil’s potential melanoma turned out to be CLL

Ongoing fatigue was the symptom that prompted Phil Nicholls to have his first medical assessment in years and it resulted in his diagnosis with chronic lymphocytic leukaemia (CLL). 

  • Chronic lymphocytic leukaemia
Read more
Phil Nicholls and Cheryll

Expert Series: Professor John Seymour

Find out why the clinical haematologist is dedicating his life to CLL.

  • Chronic lymphocytic leukaemia
  • Interviews with experts
Read more
John Seymour

Patients retain remission for 10+ years after CAR T-cell therapy

It’s 10 years since the first CLL patients were treated with CAR T-cell therapy and they are still in remission.

  • Chronic lymphocytic leukaemia
  • Treatments and side-effects
Read more
Illustration of various treatments, pills, medicines

The fear, worry, and relief of having and recovering from COVID-19

In March 2022, member of the Blood Cancer Taskforce and Cancer Australia's Advisory Council Deborah Henderson found out she had COVID-19. Here, she shares her first-person narrative of that experience.

  • Chronic lymphocytic leukaemia
Read more
Deborah Henderson

“CAR-T could be my cure,” says Deborah

Delighted, really relieved, and excited was Deborah Henderson’s response to her nine-month review following CAR T-cell therapy last year. 

  • Chronic lymphocytic leukaemia
Read more
When the Sims family returned from the UK in March 2016